Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

• Hoofdauteurs: Elsie Grace (Auteur), Orin Goldblum (Auteur), Lisa Renda (Auteur), Noah Agada (Auteur), Kyoungah See (Auteur), Craig Leonardi (Auteur), Alan Menter (Auteur)
• Formaat: Boek
• Gepubliceerd in: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Introduction Biologics used to treat moderate-to-severe plaque psoriasis may cause injection site reactions (ISRs) characterized by erythema, edema, itch, and sometimes pain. The Federal Adverse Event Reporting System (FAERS) is a repository of spontaneous post-marketing reports of adverse...